av/sernova--big.svg

NASDAQ:SVA

Sinovac Biotech Ltd.

  • Stock

USD

Last Close

6.47

28/08 20:00

Market Cap

464.94M

Beta: -

PE Ratio

5.65

PFCF: −0.40

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
71.77M
-
62.93M
12.32%
67.41M
7.12%
72.43M
7.44%
174.35M
140.71%
229.65M
31.72%
246.05M
7.14%
510.62M
107.53%
19.37B
3,694.36%
1.49B
92.30%
448.27M
69.97%
cost of revenue
20.50M
-
15.48M
24.53%
18.41M
18.95%
22.39M
21.65%
20.24M
9.61%
24.72M
22.15%
32.47M
31.33%
67.18M
106.91%
1.07B
1,496.04%
684.46M
36.16%
181.52M
73.48%
gross profit
51.27M
-
47.46M
7.44%
49.01M
3.27%
50.04M
2.11%
154.11M
207.98%
204.93M
32.98%
213.58M
4.22%
443.44M
107.62%
18.30B
4,027.39%
808.30M
95.58%
266.75M
67.00%
selling and marketing expenses
general and administrative expenses
41.98M
-
137.00M
-
121.47M
11.34%
176.53M
45.33%
591.17M
234.87%
selling general and administrative expenses
33.61M
-
34.34M
2.16%
37.48M
9.15%
41.98M
12.00%
87.36M
108.11%
137.00M
56.82%
121.47M
11.34%
176.53M
45.33%
591.17M
234.87%
823.54M
39.31%
468.96M
43.06%
research and development expenses
8.13M
-
10.93M
34.52%
9.49M
13.21%
12.65M
33.28%
20.49M
61.99%
21.91M
6.94%
24.25M
10.70%
48.76M
101.04%
155.04M
217.97%
442.11M
185.16%
344.51M
22.07%
other expenses
329K
-
1.19M
260.49%
-174K
114.67%
100K
157.47%
13K
87%
321K
2,369.23%
912K
184.11%
496K
45.61%
-89.95M
18,234.68%
301.75M
435.47%
cost and expenses
61.74M
-
60.97M
1.24%
63.69M
4.46%
71.45M
12.18%
128.89M
80.39%
184.26M
42.96%
177.20M
3.83%
294.82M
66.38%
1.82B
517.56%
1.95B
7.30%
994.99M
49.07%
operating expenses
41.23M
-
45.50M
10.34%
45.28M
0.47%
49.06M
8.33%
108.65M
121.48%
159.54M
46.84%
144.73M
9.28%
227.64M
57.29%
748.45M
228.79%
1.27B
69.57%
813.48M
35.90%
interest expense
3.03M
-
3.41M
12.41%
1.92M
43.65%
1.73M
9.95%
1.57M
9.25%
1.07M
31.80%
650K
39.25%
1.45M
123.54%
2.84M
95.18%
1.26M
55.43%
2.26M
78.80%
ebitda
18.94M
-
13.93M
26.43%
11.22M
19.46%
7.12M
36.52%
51.54M
623.52%
52.86M
2.58%
76.58M
44.86%
222.27M
190.24%
17.65B
7,842.45%
188.31M
98.93%
-401.98M
313.46%
operating income
9.95M
-
1.89M
81.05%
3.69M
96.02%
504K
86.36%
45.42M
8,911.31%
45.32M
0.22%
68.56M
51.30%
215.64M
214.52%
17.55B
8,039.92%
-466.07M
102.66%
-546.72M
17.31%
depreciation and amortization
6.41M
-
8.10M
26.47%
6.52M
19.56%
5.31M
18.55%
4.88M
8.08%
5.14M
5.22%
4.82M
6.21%
4.04M
16.19%
86.83M
2,050.90%
156.60M
80.34%
144.75M
7.57%
total other income expenses net
241K
-
1.11M
361.41%
-200K
117.99%
-378K
89%
-29K
92.33%
246K
948.28%
618K
151.22%
333K
46.12%
-90.92M
27,404.80%
296.54M
426.13%
393.69M
32.76%
income before tax
9.41M
-
2.35M
75.05%
2.76M
17.38%
-394K
114.30%
45.04M
11,532.49%
46.58M
3.42%
70.82M
52.03%
216.62M
205.87%
17.56B
8,007.88%
25.24M
99.86%
-153.03M
706.36%
income tax expense
-2.23M
-
2.07M
192.99%
2.98M
44.27%
2.66M
10.75%
8.34M
213.03%
10.47M
25.58%
5.61M
46.48%
31.44M
460.89%
3.10B
9,773.82%
-62.89M
102.03%
105.32M
267.46%
net income
7.44M
-
-1.51M
120.36%
-1.42M
6.53%
-596K
57.91%
25.81M
4,430.03%
21.78M
15.60%
44.93M
106.27%
110.37M
145.65%
8.47B
7,571.97%
113.87M
98.66%
-99.92M
187.75%
weighted average shs out
55.30M
-
55.68M
0.69%
56.31M
1.14%
56.95M
1.13%
57.03M
0.15%
64.73M
13.49%
94.88M
46.58%
98.90M
4.24%
99.31M
0.42%
99.50M
0.19%
99.61M
0.11%
weighted average shs out dil
55.80M
-
55.68M
0.22%
56.31M
1.14%
56.95M
1.13%
57.10M
0.27%
64.98M
13.79%
109.69M
68.82%
113.66M
3.62%
114.01M
0.30%
114.17M
0.15%
99.61M
12.76%
eps
0.13
-
-0.03
120.92%
-0.03
7.72%
-0.01
58.17%
0.45
4,385.71%
0.34
24.44%
0.42
23.53%
1.06
152.38%
85.20
7,937.74%
1.08
98.73%
-1
192.59%
epsdiluted
0.13
-
-0.03
120.92%
-0.03
7.72%
-0.01
58.17%
0.45
4,385.71%
0.34
24.44%
0.41
20.59%
0.97
136.59%
74.27
7,556.70%
1
98.65%
-1
200%

All numbers in USD (except ratios and percentages)